COVID-19 Impact on Thalassemia Market, Global Research Reports 2020-2021

Publisher Name :
Date: 21-May-2020
No. of pages: 98
Inquire Before Buying

This report covers market size and forecasts of Thalassemia, including the following market information:

- Global Thalassemia Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Thalassemia Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Thalassemia Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Thalassemia Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players

Major competitors identified in this market include Bluebird bio, Inc., Acceleron Pharma, Inc., Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, Kiadis Pharma, La Jolla Pharmaceutical Company, IONIS Pharmaceuticals, etc.

Based on the Region:

- Asia-Pacific (China, Japan, South Korea, India and ASEAN)

- North America (US and Canada)

- Europe (Germany, France, UK and Italy)

- Rest of World (Latin America, Middle East & Africa)

Based on the Type:

- Iron Chelating Drugs

- Others

Based on the Application:

- Hospital

- Clinic

- Research Institute

- Laboratories

COVID-19 Impact on Thalassemia Market, Global Research Reports 2020-2021

Table of Contents
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Thalassemia Industry
1.7 COVID-19 Impact: Thalassemia Market Trends
2 Global Thalassemia Quarterly Market Size Analysis
2.1 Thalassemia Business Impact Assessment - COVID-19
2.1.1 Global Thalassemia Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Thalassemia Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Thalassemia Quarterly Market Size, 2019 VS 2020
3.2 By Players, Thalassemia Headquarters and Area Served
3.3 Date of Key Players Enter into Thalassemia Market
3.4 Key Players Thalassemia Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Thalassemia Segments, By Type
4.1 Introduction
1.4.1 Iron Chelating Drugs
1.4.2 Others
4.2 By Type, Global Thalassemia Market Size, 2019-2021
5 Impact of Covid-19 on Thalassemia Segments, By Application
5.1 Overview
5.5.1 Hospital
5.5.2 Clinic
5.5.3 Research Institute
5.5.4 Laboratories
5.2 By Application, Global Thalassemia Market Size, 2019-2021
5.2.1 By Application, Global Thalassemia Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Bluebird bio, Inc.
7.1.1 Bluebird bio, Inc. Business Overview
7.1.2 Bluebird bio, Inc. Thalassemia Quarterly Revenue, 2020
7.1.3 Bluebird bio, Inc. Thalassemia Product Introduction
7.1.4 Bluebird bio, Inc. Response to COVID-19 and Related Developments
7.2 Acceleron Pharma, Inc.
7.2.1 Acceleron Pharma, Inc. Business Overview
7.2.2 Acceleron Pharma, Inc. Thalassemia Quarterly Revenue, 2020
7.2.3 Acceleron Pharma, Inc. Thalassemia Product Introduction
7.2.4 Acceleron Pharma, Inc. Response to COVID-19 and Related Developments
7.3 Celgene Corporation
7.3.1 Celgene Corporation Business Overview
7.3.2 Celgene Corporation Thalassemia Quarterly Revenue, 2020
7.3.3 Celgene Corporation Thalassemia Product Introduction
7.3.4 Celgene Corporation Response to COVID-19 and Related Developments
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Business Overview
7.4.2 GlaxoSmithKline plc Thalassemia Quarterly Revenue, 2020
7.4.3 GlaxoSmithKline plc Thalassemia Product Introduction
7.4.4 GlaxoSmithKline plc Response to COVID-19 and Related Developments
7.5 Incyte Corporation
7.5.1 Incyte Corporation Business Overview
7.5.2 Incyte Corporation Thalassemia Quarterly Revenue, 2020
7.5.3 Incyte Corporation Thalassemia Product Introduction
7.5.4 Incyte Corporation Response to COVID-19 and Related Developments
7.6 Gamida Cell
7.6.1 Gamida Cell Business Overview
7.6.2 Gamida Cell Thalassemia Quarterly Revenue, 2020
7.6.3 Gamida Cell Thalassemia Product Introduction
7.6.4 Gamida Cell Response to COVID-19 and Related Developments
7.7 Kiadis Pharma
7.7.1 Kiadis Pharma Business Overview
7.7.2 Kiadis Pharma Thalassemia Quarterly Revenue, 2020
7.7.3 Kiadis Pharma Thalassemia Product Introduction
7.7.4 Kiadis Pharma Response to COVID-19 and Related Developments
7.8 La Jolla Pharmaceutical Company
7.8.1 La Jolla Pharmaceutical Company Business Overview
7.8.2 La Jolla Pharmaceutical Company Thalassemia Quarterly Revenue, 2020
7.8.3 La Jolla Pharmaceutical Company Thalassemia Product Introduction
7.8.4 La Jolla Pharmaceutical Company Response to COVID-19 and Related Developments
7.9 IONIS Pharmaceuticals
7.9.1 IONIS Pharmaceuticals Business Overview
7.9.2 IONIS Pharmaceuticals Thalassemia Quarterly Revenue, 2020
7.9.3 IONIS Pharmaceuticals Thalassemia Product Introduction
7.9.4 IONIS Pharmaceuticals Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of Tables
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Thalassemia Assessment
Table 9. COVID-19 Impact: Thalassemia Market Trends
Table 10. COVID-19 Impact Global Thalassemia Market Size
Table 11. Global Thalassemia Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Thalassemia Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Thalassemia Market Growth Drivers
Table 14. Global Thalassemia Market Restraints
Table 15. Global Thalassemia Market Opportunities
Table 16. Global Thalassemia Market Challenges
Table 17. By Players, Thalassemia Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Thalassemia Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Thalassemia Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Thalassemia Market
Table 21. Key Players Thalassemia Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Thalassemia Market Size 2019-2021, (US$ Million)
Table 24. Global Thalassemia Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Thalassemia Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Thalassemia Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Thalassemia Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Thalassemia Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Thalassemia Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Thalassemia Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Thalassemia Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Thalassemia Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Thalassemia Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Thalassemia Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Thalassemia Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Thalassemia Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Thalassemia Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Thalassemia Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Thalassemia Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Thalassemia Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Thalassemia Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Thalassemia Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Thalassemia Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Thalassemia Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Thalassemia Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Thalassemia Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Thalassemia Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Thalassemia Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Thalassemia Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Thalassemia Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Thalassemia Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Thalassemia Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Thalassemia Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Thalassemia Market Size, 2019-2021 (US$ Million)
Table 57. Bluebird bio, Inc. Business Overview
Table 58. Bluebird bio, Inc. Thalassemia Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Bluebird bio, Inc. Thalassemia Product
Table 60. Bluebird bio, Inc. Response to COVID-19 and Related Developments
Table 61. Acceleron Pharma, Inc. Business Overview
Table 62. Acceleron Pharma, Inc. Thalassemia Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Acceleron Pharma, Inc. Thalassemia Product
Table 64. Acceleron Pharma, Inc. Response to COVID-19 and Related Developments
Table 65. Celgene Corporation Business Overview
Table 66. Celgene Corporation Thalassemia Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Celgene Corporation Thalassemia Product
Table 68. Celgene Corporation Response to COVID-19 and Related Developments
Table 69. GlaxoSmithKline plc Business Overview
Table 70. GlaxoSmithKline plc Thalassemia Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. GlaxoSmithKline plc Thalassemia Product
Table 72. GlaxoSmithKline plc Response to COVID-19 and Related Developments
Table 73. Incyte Corporation Business Overview
Table 74. Incyte Corporation Thalassemia Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Incyte Corporation Thalassemia Product
Table 76. Incyte Corporation Response to COVID-19 and Related Developments
Table 77. Gamida Cell Business Overview
Table 78. Gamida Cell Thalassemia Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Gamida Cell Thalassemia Product
Table 80. Gamida Cell Response to COVID-19 and Related Developments
Table 81. Kiadis Pharma Business Overview
Table 82. Kiadis Pharma Thalassemia Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Kiadis Pharma Thalassemia Product
Table 84. Kiadis Pharma Response to COVID-19 and Related Developments
Table 85. La Jolla Pharmaceutical Company Business Overview
Table 86. La Jolla Pharmaceutical Company Thalassemia Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. La Jolla Pharmaceutical Company Thalassemia Product
Table 88. La Jolla Pharmaceutical Company Response to COVID-19 and Related Developments
Table 89. IONIS Pharmaceuticals Business Overview
Table 90. IONIS Pharmaceuticals Thalassemia Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. IONIS Pharmaceuticals Thalassemia Product
Table 92. IONIS Pharmaceuticals Response to COVID-19 and Related Developments
List of Figures
Figure 1. Thalassemia Product Picture
Figure 2. Thalassemia Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Thalassemia Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Thalassemia Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Thalassemia Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Thalassemia Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Thalassemia Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Thalassemia Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Thalassemia Market Size Market Share, 2019-2021
  • COVID-19 Impact on Global Aircraft Defibrillators Market Insights, Forecast to 2026
    Published: 05-Jun-2020        Price: US 4900 Onwards        Pages: 114
    Aircraft Defibrillators market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aircraft Defibrillators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Aircraft Defibrillators market is segmented into - Automatic Type - Manual......
  • COVID-19 Impact on Global Pituitary Cancer Market Size, Status and Forecast 2020-2026
    Published: 05-Jun-2020        Price: US 3900 Onwards        Pages: 97
    This report focuses on the global Pituitary Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pituitary Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - Trinity Biotech - Salzman - Genentech - Sigma-Aldrich - Varian Medical Systems - Elekta - Accuray Incorporated......
  • COVID-19 Impact on Global ECG Stress Testing System Market Size, Status and Forecast 2020-2026
    Published: 05-Jun-2020        Price: US 3900 Onwards        Pages: 97
    This report focuses on the global ECG Stress Testing System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the ECG Stress Testing System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - Mortara Instrument - Mindray Medical - Spacelabs Healthcare - Schiller AG - Koninklijke - Philips NV......
  • COVID-19 Impact on Global OR Integration System Market Size, Status and Forecast 2020-2026
    Published: 05-Jun-2020        Price: US 3900 Onwards        Pages: 90
    This report focuses on the global OR Integration System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the OR Integration System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - Stryker - Arthrex - CONMED - KARL STORZ - Olympus - Richard Wolf - Getinge AB - Doricon ......
  • COVID-19 Impact on Global HD Endoscopic Camera Market Insights, Forecast to 2026
    Published: 05-Jun-2020        Price: US 4900 Onwards        Pages: 116
    HD Endoscopic Camera market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HD Endoscopic Camera market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the HD Endoscopic Camera market is segmented into - HD Camera - 4K Camera ......
  • COVID-19 Impact on Global Vaccine Storage Equipment Market Insights, Forecast to 2026
    Published: 05-Jun-2020        Price: US 4900 Onwards        Pages: 110
    Vaccine Storage Equipment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vaccine Storage Equipment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Vaccine Storage Equipment market is segmented into - Refrigerated Storage Equ......
  • COVID-19 Impact on Global Interventional X-ray Contrast and Imaging Agents Market Insights, Forecast to 2026
    Published: 05-Jun-2020        Price: US 4900 Onwards        Pages: 113
    Interventional X-ray Contrast and Imaging Agents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interventional X-ray Contrast and Imaging Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Interventional X-ray Contrast and Imag......
  • COVID-19 Impact on Global Endoscopic Camera Market Insights, Forecast to 2026
    Published: 05-Jun-2020        Price: US 4900 Onwards        Pages: 118
    Endoscopic Camera market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Endoscopic Camera market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Endoscopic Camera market is segmented into - HD Camera - 3D Camera Segm......
  • COVID-19 Impact on Global Surgical Visualization Product Market Size, Status and Forecast 2020-2026
    Published: 05-Jun-2020        Price: US 3900 Onwards        Pages: 127
    This report focuses on the global Surgical Visualization Product status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Surgical Visualization Product development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - Karl Storz Gmbh - Medtronic - CONMED - Boston Scientific - COOK GROUP - Smith & Nephew......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs